Well-established circulating tumor markers include the prostate-specific antigen (PSA) for prostate cancer screening [8] and carbohydrate antigen 19 − 9 (CA19-9) for postoperative follow-up of pancreatic cancer recurrence [9]. This evidence concerns the gene KLK3 and pancreatic neoplasm.